BioWorld

BioWorld is a suite of news services that delivers critical information on the latest and most innovative therapeutics and medical technologies in development.

Subscribe for the latest pharma, biotech and medtech news. Full website access for all four news services! Full editions delivered every business day plus midday alerts and breaking news bulletins.

With writers and editors located around the globe, it provides breaking news and essential perspectives on hundreds of therapeutics and devices in development, the companies behind those candidates, the business development transactions that shape the market, and the regulatory hurdles that challenge the processes.



Get daily insights into the latest developments in the biotechnology, pharmaceutical, and medical technology industries with Biopharma, the go-to news source for trusted and comprehensive coverage.

You can access the website from a newer Windows 11, 10, or 7 computer or laptop, as well as from any browser such as Chrome, Firefox, Opera, and similar ones.

Overview & Review

BioWorld has a long tradition of excellence in journalism, with its news services being honored with 56 awards from the Specialized Information Publishing Association dating back to 1998.

These accolades include placement in the overall best daily publication category 13 times, reflecting BioWorld's commitment to high-quality journalism and its ability to deliver accurate and actionable intelligence to its readers.

The history of BioWorld is a testament to the foresight of its founders, David Bunnell and Cynthia Robbins-Roth, who launched the magazine in 1990. Bunnell, a pioneer of the personal computing industry, had the idea that biotechnology would become a significant field, and he was right.

It quickly became a faxed publication called BioWorld Today, which provided a weekly look at financial trends in the biopharmaceutical industry. In 1994, it was acquired by Thompson Media Group, and the faxed version was discontinued in favor of digital delivery.

It has continued to evolve and expand its offerings over the years, adapting to the changing needs of its readers.

BioWorld's suite of news services includes BioWorld MedTech, which was launched in 1997 as The BBI Newsletter, and later became Medical Device Daily, focusing on the medical technology industry. In 2017, the news service was rebranded as BioWorld MedTech, reflecting its focus on the intersection of technology and medicine.

BioWorld Science, originally called Prous Science Daily Essentials, joined the group in 2018. BioWorld Science provides news and insights on discovery and preclinical research to support drug R&D decisions at the earliest stages.

This news service delivers competitive scientific intelligence about novel compounds and those in development across all therapy areas, drawing from multiple information sources.

BioWorld Asia was launched in 2013 in response to the increasing demand for more news from this region. BioWorld Asia provides biopharmaceutical executives with a trusted, steady stream of intelligence from this critical part of the world.

The service reports on the latest developments in the region, including regulatory updates, clinical trial data, and business transactions.

BioWorld publications

BioWorld
Stay up-to-date with the latest news in biotechnology, pharmaceuticals, and medical technology with daily newsletter, mid-day alerts, and breaking news delivered straight to your inbox. Access new and archived articles on-the-go and easily search for information online. The expert insights and behind-the-scenes interviews with industry leaders offer valuable perspectives and analysis.

BioWorld MedTech
Get exclusive daily newsletters, mid-day alerts, and breaking news focused solely on medical devices and technologies. All news is delivered in a digital format with a complete repository available online for easy searching. Stay informed about R&D, clinical trials, regulatory updates, financings, M&As, and other key industry updates.

BioWorld Asia
Keep up with life sciences news from the Asia Pacific region with weekly updates from on-the-ground experts and breaking news updates on industry conferences. Stay informed about R&D, clinical trials, regulatory updates, deals, M&As, and other key regional updates.

BioWorld Science
Stay current with daily updates and breaking news focused on drug discovery and pre-clinical research. Access all of articles online and easily organize them by therapeutic area for easy searching. Stay up-to-date with coverage of scientific congresses, industry conferences, innovative publications, and more.

Main Features

Facilitate Informed Decision-Making
Empower confident decision-making through unbiased reporting, factual news, and analyses by experienced and award-winning journalists across the globe. With direct source interviews, intensive background research, and reliable data from trusted sources, news service provides valuable insights for a wide range of decisions.

Tailored to Your Company's Needs
Stay updated on the latest developments in therapeutic product development across your region or topics of interest through comprehensive coverage and extensive archives of global biopharma and medtech news, trends, and analyses. The news service focuses on topics that matter most to your company, enabling you to make informed decisions and stay ahead of the curve.

Track Industry Competition
Stay on top of the latest industry developments through integrated Cortellis™ data analysis and embedded links in articles that lead to related Cortellis content. By monitoring your competition, you can gain a competitive advantage and make strategic decisions based on the latest industry insights.

Clarivate Products & Services

Scientific & Academic Research

• Discovery & Workflow
• Analytics, Evaluation & Management
• Publishing
• Libraries, Teaching & Learning

Biopharma Intelligence

• Research & Development
• Pharmacovigilance & Drug Safety
• Regulatory & Compliance
• Portfolio Strategy & Business Development
• Commercial & Launch Strategy
• Generics & Manufacturing
• Market Access
• Customer Engagement

Medtech Intelligence

• Strategic Portfolio Planning
• Launch Strategy
• Commercial Effectiveness
• Market Access
• Product Lifecycle Management

IP Intelligence

• IP Litigation Intelligence Solutions
• Patent Intelligence Software
• Patent Search & Analytics
• Trademark Research & Protection
• Chemistry & Life Science
• IP Data & APIs

IP Lifecycle Management

• IP Management Software
• Network Collaboration Tools

IP Services

• Patent & Trademark Maintenance
• Filing & Prosecution Support
• Patent Translations Services

Consulting & Data

• Consulting Services
• Data integration and custom analytics
• Real World Data
• Research Reports
• Market Intelligence Data

BioWorld Subscription

Bioworld offers a subscription service that provides users with daily news and analysis on the global biotechnology, pharmaceutical, and medical technology industries.

With a team of experienced and award-winning journalists stationed around the world, Bioworld provides reliable and unbiased reporting, fact-based news, and analysis via direct source interviews and intensive background research.

Does BioWorld have a free trial version?

Yes, BioWorld offers a free trial version of its news services to potential subscribers. The trial version is designed to give users a taste of what BioWorld has to offer and allows them to evaluate whether the service will meet their needs.

The trial version typically lasts for a limited time, usually a 14 days, during which users have access to a selection of BioWorld's latest news and analysis. This includes breaking news, in-depth articles, company and product profiles, and expert insights and interviews.

To access the trial version, users typically need to register with BioWorld and provide some basic information about themselves and their interests. Once registered, users can then log in to the website and start exploring the trial version.

During the trial period, users are encouraged to provide feedback to BioWorld about their experience and any suggestions they may have for improving the service. This feedback is taken seriously by BioWorld and is used to help shape the future development of the service.

At the end of the trial period, users are given the option to subscribe to BioWorld's full news services. If they choose to subscribe, they will have access to all of BioWorld's news and analysis, including daily newsletters, breaking news alerts, and in-depth coverage of the biotechnology, pharmaceutical, and medical technology industries.

Pricing (Subscribe for the latest pharma, biotech and medtech news)

BioWorld
The news source of record covering the development of innovative human therapies for 30 years.

• Website access to BioWorld content
• Full editions delivered every business day by 8 pm ET plus midday alerts and breaking news bulletins
• 14 days free then $333/month

BioWorld MedTech
The news source of record covering the latest advances in medical technology.

• Website access to BioWorld MedTech content
• Full editions delivered every business day by 8 pm ET plus midday alerts and breaking news bulletins
• 14 days free then $292/month

BioWorld Premium
Get it all! Full-site access (excluding BioWorld Science) plus e-newsletters

• Full website access for all three news services
• Full editions delivered every business day by 8 pm ET plus midday alerts and breaking news bulletins
• 14 days free then $500/month

PROS

Comprehensive Coverage
Extensive news on biotech, pharma, and medtech.

Award-Winning Journalism
Recognized for high-quality, unbiased reporting.

Global Reach
Insight from journalists worldwide for broad perspectives.

Exclusive Insights
Direct interviews and in-depth analyses for decision-making.

Flexible Subscription Plans
Tailored plans to fit varied needs and access levels.

CONS

No Access to BioWorld Science in Premium
Premium plan excludes full BioWorld Science access.

Digital-Only Format
Exclusively online; no printed editions available.

Region-Specific Focus
Heavy focus on certain regions may miss global nuances.

Conclusion

In conclusion, BioWorld's suite of news services provides critical intelligence on the latest and most innovative therapeutics and medical technologies in development.

With a long tradition of excellence in journalism, BioWorld delivers accurate and actionable information to its readers, helping them stay informed and make informed decisions.